A word from our Director

Michel Bouvier_300ppSince more than 10 years, we have developed a high-performance cancer research centre with the mission of developing new, more effective therapies to treat this disease. Everything has been put in place to accelerate our discoveries and to allow us to have a tangible impact in our fight against cancer. We have recruited the finest researchers in their fields and have provided a state-of-the-art environment in which they can thrive. We have created a graduate study program that attracts the most promising young scientists and train them to become tomorrow’s leading investigators. We have set up the first Canadian anticancer drug discovery chain in academia. We have also developed our links with the biopharmaceutical industry by creating IRICoR.

But what distinguishes us most is that we have implemented a true culture of collaboration and multidisciplinarity at the heart of our Institute. This approach allows us to develop partnerships with various stakeholders such as researchers, the clinical community, the pharmaceutical industry, equipment manufacturers, philanthropists, and business leaders. We believe that the synergy brought on by our joint efforts will bring us closer to accomplishing our ambitious mission.

Thanks to our numerous partnerships and our distinctive research model, IRIC has established itself as one of the country’s most important cancer research hubs. Our innovating approach to research has already led to discoveries that will, over the coming years, have a significant impact in our battle to counter this plague that continues to afflict too many of us.

I invite you to browse our website to learn more about our Institute and how you can take part in our success as a researcher, a student, an employee, or a donor.

Enjoy your visit!

Michel Bouvier, Ph.D., FCAHS, FRSC
IRIC Chief Executive Officer

Follow IRIC

Logo UdeM